Healthcare provider profile · identity verified

Curtis R Evans, MD

Internal Medicine · FORT WORTH, TX · NPI 1538185483

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	547	151
Losartan Potassium	Losartan Potassium	380	105
Amlodipine Besylate	Amlodipine Besylate	349	103
Levothyroxine Sodium	Levothyroxine Sodium	328	91
Gabapentin	Gabapentin	263	82
Metformin Hcl	Metformin Hcl	244	76
Lisinopril	Lisinopril	241	71
Metoprolol Succinate	Metoprolol Succinate	213	64
Pantoprazole Sodium	Pantoprazole Sodium	204	65
Rosuvastatin Calcium	Rosuvastatin Calcium	191	58
Trazodone Hcl	Trazodone Hcl	170	49
Pravastatin Sodium	Pravastatin Sodium	163	46
Tamsulosin Hcl	Tamsulosin Hcl	148	44
Eliquis	Apixaban	145	37
Duloxetine Hcl	Duloxetine Hcl	143	38
Hydrochlorothiazide	Hydrochlorothiazide	143	43
Furosemide	Furosemide	132	38
Atenolol	Atenolol	120	31
Glipizide	Glipizide	118	38
Omeprazole	Omeprazole	113	26
Escitalopram Oxalate	Escitalopram Oxalate	96	34
Clopidogrel	Clopidogrel Bisulfate	92	27
Montelukast Sodium	Montelukast Sodium	91	30
Alendronate Sodium	Alendronate Sodium	89	25
Allopurinol	Allopurinol	86	25
Albuterol Sulfate Hfa	Albuterol Sulfate	82	30
Alprazolam	Alprazolam	82	22
Carvedilol	Carvedilol	80	25
Potassium Chloride	Potassium Chloride	76	22
Simvastatin	Simvastatin	73	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	72	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	20
Ozempic	Semaglutide	68	suppressed
Ezetimibe	Ezetimibe	67	19
Famotidine	Famotidine	63	17
Sertraline Hcl	Sertraline Hcl	63	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	61	19
Finasteride	Finasteride	59	24
Donepezil Hcl	Donepezil Hcl	56	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	15
Tramadol Hcl	Tramadol Hcl	53	14
Tizanidine Hcl	Tizanidine Hcl	52	31
Amoxicillin	Amoxicillin	51	44
Trulicity	Dulaglutide	51	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	48	13
Prednisone	Prednisone	44	28
Nifedipine Er	Nifedipine	43	11
Pregabalin	Pregabalin	43	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	19
Memantine Hcl	Memantine Hcl	42	13
Azithromycin	Azithromycin	41	39
Benazepril Hcl	Benazepril Hcl	41	14
Meloxicam	Meloxicam	41	11
Jardiance	Empagliflozin	39	suppressed
Farxiga	Dapagliflozin Propanediol	36	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Humalog Kwikpen U-100	Insulin Lispro	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Tresiba Flextouch U-100	Insulin Degludec	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	11
Spironolactone	Spironolactone	29	11
Buspirone Hcl	Buspirone Hcl	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Glimepiride	Glimepiride	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Raloxifene Hcl	Raloxifene Hcl	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	20
Valsartan	Valsartan	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	20
Lovastatin	Lovastatin	23	suppressed
Torsemide	Torsemide	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	16
Creon	Lipase/Protease/Amylase	17	suppressed
Fluocinonide	Fluocinonide	17	suppressed
Ibandronate Sodium	Ibandronate Sodium	17	suppressed
Methylprednisolone	Methylprednisolone	17	15
Mounjaro	Tirzepatide	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	15	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Acyclovir	Acyclovir	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Etodolac	Etodolac	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error